title: T-cell involvement in delayed-type hypersensitivity reactions to infliximab.
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Torres
authors.forename: Patrícia
authors.initials: P
authors.lastname: Chaves
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Doña
authors.forename: Natalia
authors.initials: N
authors.lastname: Blanca-López
authors.forename: Gabriela
authors.initials: G
authors.lastname: Canto
authors.forename: Cristobalina
authors.initials: C
authors.lastname: Mayorga
authors.forename: Miguel
authors.initials: M
authors.lastname: Blanca
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology; D002469:Cell Separation; D004342:Drug Hypersensitivity / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D005260:Female; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D016130:Immunophenotyping; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab